We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00294736
Recruitment Status : Completed
First Posted : February 22, 2006
Last Update Posted : August 8, 2012
Information provided by (Responsible Party):
Astellas Pharma Inc ( OSI Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2007
  Study Completion Date : September 2007